Guardant Health is focused on conquering cancer by using its breakthrough blood-based assays, vast data sets, and advanced analytics. Using both molecular and digital tools, Guardant Health is addressing challenges across the cancer care continuum. Its first product, the Guardant360 assay, is the most widely ordered comprehensive liquid biopsy commercially available.
